About Michelson Diagnostics
Michelson Diagnostics is a company based in Maidstone (United Kingdom) founded in 2006. It operates as a B2B. Michelson Diagnostics has raised $14.87 million across 6 funding rounds from investors including Smith & Nephew, Kent County Council and Octopus Investments. The company has 11 employees as of September 30, 2021. Michelson Diagnostics offers products and services including VivoSight OCT Scanner. Michelson Diagnostics operates in a competitive market with competitors including Castle Biosciences, DermTech, SpectraWAVE, NinePoint Medical and DermaSensor, among others.
- Headquarter Maidstone, United Kingdom
- Employees 11 as on 30 Sep, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Michelson Diagnostics Ltd
- Date of Incorporation 07 Mar, 2006
- Jurisdiction NOTTINGHAM, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.87 M (USD)
in 6 rounds
-
Latest Funding Round
$3.8 M (USD), Series B
Feb 09, 2015
-
Investors
Smith & Nephew
& 7 more
-
Employee Count
11
as on Sep 30, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Michelson Diagnostics
Michelson Diagnostics offers a comprehensive portfolio of products and services, including VivoSight OCT Scanner. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides non-invasive imaging for skin and tissue examination in clinics.
Funding Insights of Michelson Diagnostics
Michelson Diagnostics has successfully raised a total of $14.87M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $3.8 million completed in February 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series B — $3.8M
-
First Round
First Round
(06 Jan 2010)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2015 | Amount | Series B - Michelson Diagnostics | Valuation | Smith & Nephew | |
| Dec, 2013 | Amount | Series A - Michelson Diagnostics | Valuation | Octopus Investments | |
| Mar, 2012 | Amount | Seed - Michelson Diagnostics | Valuation | London Business Angels , Octopus Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Michelson Diagnostics
Michelson Diagnostics has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Smith & Nephew, Kent County Council and Octopus Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment and support for founders in technology and health sectors.
|
Founded Year | Domain | Location | |
|
Investment solutions are provided by Catapult Ventures for growth.
|
Founded Year | Domain | Location | |
|
Manufacturer of knee, hip and shoulder joint replacements
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Michelson Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Michelson Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Michelson Diagnostics Comparisons
Competitors of Michelson Diagnostics
Michelson Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Castle Biosciences, DermTech, SpectraWAVE, NinePoint Medical and DermaSensor, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
Adhesive patch biopsies for skin cancer detection are provided.
|
|
| domain | founded_year | HQ Location |
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
|
|
| domain | founded_year | HQ Location |
Optical coherence tomography systems for tissue microstructure imaging are developed.
|
|
| domain | founded_year | HQ Location |
Handheld diagnostic device for skin cancer lesions is developed.
|
|
| domain | founded_year | HQ Location |
Biological tissue imaging is developed using optical coherence tomography.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Michelson Diagnostics
Frequently Asked Questions about Michelson Diagnostics
When was Michelson Diagnostics founded?
Michelson Diagnostics was founded in 2006 and raised its 1st funding round 4 years after it was founded.
Where is Michelson Diagnostics located?
Michelson Diagnostics is headquartered in Maidstone, United Kingdom.
Is Michelson Diagnostics a funded company?
Michelson Diagnostics is a funded company, having raised a total of $14.87M across 6 funding rounds to date. The company's 1st funding round was a Seed of $955.36K, raised on Jan 06, 2010.
How many employees does Michelson Diagnostics have?
As of Sep 30, 2021, the latest employee count at Michelson Diagnostics is 11.
What does Michelson Diagnostics do?
Michelson Diagnostics specializes in creating advanced medical imaging technology, including the VivoSight OCT scanner for non-invasive skin and tissue examination. The company operates from its headquarters in the UK, with additional offices in Germany and the US, focusing on optical coherence tomography innovations. They engage in partnerships, investments, and provide systems for clinical applications, emphasizing shareholder value and product development.
Who are the top competitors of Michelson Diagnostics?
Michelson Diagnostics's top competitors include DermTech, DermaSensor and NinePoint Medical.
What products or services does Michelson Diagnostics offer?
Michelson Diagnostics offers VivoSight OCT Scanner.
Who are Michelson Diagnostics's investors?
Michelson Diagnostics has 8 investors. Key investors include Smith & Nephew, Kent County Council, Octopus Investments, Catapult Ventures, and London Zu.